Adherence and patients’ experiences with the use of oral anticancer agents-Reference-Cited by-同舟云学术

Adherence and patients’ experiences with the use of oral anticancer agents

Published:2013-11-22 Issue:2 Volume:53 Page:259-267
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Timmers Lonneke,Boons Christel C. L. M.,Kropff Femke,van de Ven Peter M.,Swart Eleonora L.,Smit Egbert F.,Zweegman Sonja,Kroep Judith R.,Timmer-Bonte Johanna N. H.,Boven Epie,Hugtenburg Jacqueline G.

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2013.844353

Reference26 articles.

1. Use and costs of oral anticancer agents in the Netherlands in the period 2000-2008

2. Answering Patients' Needs: Oral Alternatives to Intravenous Therapy

3. Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer

4. Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial

5. Budget impact analysis of the use of oral and intravenous anti-cancer drugs for the treatment of HER2-positive metastatic breast cancer

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient reported medication-related problems, adherence and waste of oral anticancer medication over time;European Journal of Hospital Pharmacy;2024-07-17

2. A Machine Learning Model to Predict Patients’ Adherence Behavior and a Decision Support System for Patients With Metastatic Breast Cancer: Protocol for a Randomized Controlled Trial;JMIR Research Protocols;2023-12-14

3. Trends and prescribing patterns of oral anti-neoplastic drugs: a retrospective longitudinal study;Frontiers in Public Health;2023-11-23

4. A telephone follow-up management model for oral outpatient chemotherapy featuring concerted interventions by hospital and community pharmacists, and physicians;2023-10-28

5. S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis;PLOS ONE;2023-08-11